1. Chemical and structural lessons from recent successes in protein–protein interaction inhibition (2P2I)
   Xavier Morelli et al, 2011, Current Opinion in Chemical Biology CrossRef
2. A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
   Gordana Vlahovic et al, 2014, Investigational New Drugs CrossRef
3. 2P2I HUNTER : a tool for filtering orthosteric protein–protein interaction modulators via a dedicated support vector machine
   Véronique Hamon et al, 2014, Journal of The Royal Society Interface CrossRef
4. Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis
   Kevin Tan et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef
5. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
   Siyuan Zhang et al, 2012, Trends in Pharmacological Sciences CrossRef
6. Leading Small Molecule Inhibitors of Anti-Apoptotic Bcl-2 Family Members
   Victor Y. Yazbeck et al, 2013, Cell Death Signaling in Cancer Biology and Treatment CrossRef
7. A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
   Anthony W. Tolcher et al, 2014, Cancer Chemotherapy and Pharmacology CrossRef
8. Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
   Girieca Lorusso et al, 2020, Frontiers in Oncology CrossRef
9. WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors
   Yuji Sakuma et al, 2012, Laboratory Investigation CrossRef
10. Bcl‐2 family in non‐small cell lung cancer: its prognostic and therapeutic implications
    Ping‐Li Sun et al, 2017, Pathology International CrossRef
11. Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps
    Lubna Danish et al, 2018, PLOS ONE CrossRef
12. BH3-mimetics: recent developments in cancer therapy
    Paul A. Townsend et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
13. Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263
    Haikuo Tang et al, 2011, Biochemical Pharmacology CrossRef
14. Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies
    Jing Wang et al, 2022, Cancers CrossRef